combination therapy with glp-1 receptor agonist and sglt2 inhibitor Schematic illustration of monoagonists, dual agonists triple Full article: Combination SGLT2 inhibitor
Description
Some of the combinations have drawn particular interests from researchers
New techniques for improving knowledge about intestinal peptides Despite the advances made in Mutt's laboratory, the isolation and purification of intestinal peptide hormones was time-consuming and expensive
Click the bio link to listen to the full episode
However, this data does provide important pilot data regarding adjuvant GLP-1 receptor agonist therapy following bariatric surgery
